Founded in 2015 and headquartered in Boone, United States, Pneuma Respiratory specializes in innovative respiratory technology and digital health solutions. The company develops advanced drug delivery devices and respiratory products, targeting the healthcare and pharmaceutical markets.
Subscribe to see Pneuma Respiratory, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pneuma Respiratory, Inc. is a company headquartered in Boone, United States. It has raised at least $31.2M across the 8 funding rounds on record. Its most recent funding round raised $3.6M in June 2026. Xcout tracks 13 named people at Pneuma Respiratory, Inc., including C. Eric Hunter (President & CEO).
As of 16 November 2026. Source: Xcout Intel.
7 more named people on record for Pneuma Respiratory, Inc., with roles, board committees and tenure — see the full roster →
At least $31.2M raised across the 8 rounds on record. The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.6M | — | |
| SEC Form D filing | $3.3M | — | |
| SEC Form D filing | $7.3M | — | |
| SEC Form D filing | $429,585 | — | |
| SEC Form D filing | $437,794 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Pneuma Respiratory, Inc.'s closest competitors — see the full list of competitors and alternatives →
Eupnea Technologies, Inc. is a respiratory support company headquartered in the United States, operating within the health care sector.
Neshima Medical is a private medical device and therapeutics company headquartered in Dimona, Israel. The company develops innovative technologies designed to transform respiratory medicine by improving targeted drug delivery to the lungs.
NuvoAir Holdings, Inc. is a digital-health company focused on respiratory care. It provides connected spirometry devices and software for remote monitoring and management of conditions such as COPD and asthma, serving patients, clinicians, and healthcare organizations.
Pneumonics, Inc. develops PneuMotion, a continuous respiratory monitoring and obstructive apnea detection technology designed to detect opioid-induced ventilation impairment. The system integrates into hospital networks for mobile monitoring and electronic health record data collection, and also offers at-home overdose monitoring with automated emergency alerts.
Iconovo develops inhalation medicines and proprietary dry powder inhaler platforms in partnership with pharmaceutical companies. The company provides end-to-end product development services—combining patented device platforms and drug formulation expertise—to support treatments ranging from respiratory care to systemic delivery.
Inspira Technologies OXY B.H.N. Ltd. is a publicly traded medical technology company focused on developing innovative respiratory care solutions and changing oxygen treatment paradigms.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Pneuma Respiratory, Inc.? Suggest a correction · Work at Pneuma Respiratory, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.